What You Should Know:
- Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. This latest funding brings the company’s valuation to $2.2B.
- Reify Health has built a new foundation for how clinical trials are run through its
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
4G Clinical Secures $230M for Randomization and Trial Supply Management
What You Should Know:
- 4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, today announced it has entered into an agreement to receive a growth equity investment of over $230MM from Goldman Sachs Asset Management ("Goldman Sachs").
- Founded in 2015, 4G Clinical's Prancer RTSMⓇ enables life sciences companies to reach First Patient In (FPI) up to 50% faster than other providers and implement mid-study changes more efficiently. 4G Clinical's clinical
Read More
Medable Launches Decentralized Clinical Trials Enablement Program
What You Should Know:
- Medable Inc., a software platform for patient-centered drug development, today announced an industry-first digital certification program that provides life sciences companies with specialized tools, knowledge sharing and skills development to rapidly scale their decentralized and hybrid trial strategies.
- Hybrid/decentralized clinical trials have unleashed an entirely new patient experience, but this new approach to clinical research will only work if
Read More
Lightship Partners with Castor to Scale Virtual Clinical Trials Worldwide
- Lightship and Castor, providers of decentralized clinical trial solutions, today announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale. The partnership combines operational excellence in clinical studies and technology that delivers for the most complex clinical trials.
- Lightship’s end-to-end delivery model combined with an in-house care team provide the best possible patient experience in clinical trials.
- By partnering with Castor’s
Read More
Medidata Announces Decentralized Clinical Trials Program
What You Should Know:
- Today Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum.
For the first time ever, drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the only platform offering on the market which combines:
-
Read More
Hawthorne Effect Secures $20M to Decentralize Clinical Trials
What You Should Know:
- Hawthorne Effect, a San Francisco-based solution for decentralizing clinical trials, today announced it has raised $20M in Series A funding led by Northpond Ventures with participation from SignalFire and P5 Health Ventures.
- Founded in 2015, Hawthrone Effect alleviates key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals.
Hawthrone’s key offerings include:
- Hawthorne Cloud: The
Read More
Medidata Launches New Tech to Transform the Patient Clinical Trial Experience
What You Should Know:
- Today Medidata, a Dassault Systèmes company, launched myMedidata Registries – a new technology that expands and strengthens the company’s myMedidata patient portal to engage patients before and after (i.e., long term follow-up/safety surveillance) a clinical trial.
- The offering, which redefines Medidata’s end-to-end technology solutions and represents a major advance for the life sciences industry, empowers patients to
Read More
PE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&A
What You Should Know:
- Thoma Bravo, a private equity investment firm focused on the software and technology-enabled services sector announced that it has reached an agreement to acquire Greenphire, a financial lifecycle management software for clinical trials, from The Riverside Company. Financial details were not disclosed for the pending transaction.
- The acquisition, which is subject to customary regulatory approvals, is expected to close in the second quarter of this year.
-
Read More
Florence Raises $80M to Expand Connectivity Platform for Clinical Trials
What You Should Know:
- Florence, a site connectivity platform in clinical trials, today announced the close of a $80 million Series C funding round led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round.
- Based in Atlanta, GA, Florence is a global leader in remote connectivity and electronic document workflow management for
Read More
Cancer Centers: Here’s How We Can Restart Clinical Trials Today
Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
